Showing promise in the arena of weight management therapy, retatrutide is a distinct method. Different from many current medications, retatrutide operates as a twin agonist, concurrently affecting both GLP-like peptide-1 (GLP-1) and glucose-sensitive insulinotropic polypeptide (GIP) receptors. The dual stimulation promotes multiple beneficial effec